Cipta Sarana Medika Tbk. vs Hensel Davest Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Hensel Davest Indonesia Tbk. trades at Rp50 (market cap 76.23B, 3.54M 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 2.1× Hensel Davest Indonesia Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 3.54M). Which is the better fit depends on your goals.
| DKHH | HDIT | |
|---|---|---|
Market Cap | 158.12B | 76.23B |
Volume | 8.21M | 3.54M |
Lot | 82.15K | 35.39K |
Turnover | 515.2M | 176.96M |
Average Price | 62.72 | 50 |
Value | 515.2M | 176.96M |
Indicative Equilibrium Price | 63 | 50 |
Indicative Equilibrium Volume | 1.33K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.
Read more on HDIT →